Back to current studies

New Alzheimer's Disease Research

NeuroTrials Research is conducting a 26-week, placebo-controlled research study on the safety & efficacy of an investigational drug Alzheimer’s Disease. Study-related exams & study drug are provided at no cost. 


Qualified participants & caregivers will be compensated for time & travel. 

To qualify, participants must:

• be 66-90 years of age
• have a diagnosis of mild to moderate Alzheimer's Disease
• have a caregiver capable of attending all study visits
• otherwise be in general good health

For more information, call 404-851-9934 or complete the form below.